Acro Biomedical Co., Ltd. (ACBM) Stock Price & Growth Analysis

Quote Panel

Updated October 29, 2024

1W 0.00 % 1M 0.00 % 3M 0.00 % 1Y -99.93 %

Key Metrics

Market Cap
60042
Shares Outstanding
60.04M
Share in Float
30.04M
Dividende
0

Earning Date
29 Oct 2024
Price Target
0.001
Average Volume
Beta
1.004

Range
0.001-1.5
Industry
Biotechnology
Website
https://acrobiomedicalco.com
Sector
Healthcare

Fundamentals

N/A

P/E Ratio

0.09x

P/S Ratio

0.12x

P/B Ratio

0.1

Debt/Equity

-2410.2%

Net Margin

$-0.3

EPS

How ACBM compares to sector?

P/E Ratio

Relative Strength

ACBM

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings Growth

YoY

Current

Estimates

Q3.21

N/A

-0.05
vs -0.00

Q4.21

N/A

-0.07
vs -0.00

Q1.22

N/A

-0.07
vs -0.00

Q2.22

N/A

-0.07
vs -0.02

Q3.22

N/A

-0.07
vs -0.05

Q4.22

N/A

-0.07
vs -0.07

Q1.23

N/A

-0.07
vs -0.07

Q2.23

N/A

-0.05
vs -0.07

Q3.23

+2183%

1.39
vs -0.07

Q4.23

+3273%

2.08
vs -0.07

Sales Growth

YoY

Current

Estimates

Q1.21

-86%

99.5K vs 688K

Q2.21

500K vs NA

Q3.21

NA vs NA

Q4.21

598K vs NA

Q1.22

+200%

298.5K vs 99.5K

Q2.22

-100%

NA vs 500K

Q3.22

NA vs NA

Q4.22

-40%

360K vs 598K

Q1.23

-100%

NA vs 298.5K

Q2.23

NA vs NA

Return on Equity

QoQ

Q3.21

-526%

-5.26
vs -1.24

Q4.21

-599%

-5.99
vs -5.26

Q1.22

-611%

-6.11
vs -5.99

Q2.22

-695%

-6.95
vs -6.11

Q3.22

-815%

-8.15
vs -6.95

Q4.22

-809%

-8.09
vs -8.15

Q1.23

-975%

-9.75
vs -8.09

Q2.23

-941%

-9.41
vs -9.75

Institutionnal Ownership

Company Description

N/A

0.09x

0.12x

0.1

-2410.2%

$-0.3

Earnings Growth

Latest News

New Feature Coming Soon, Stay Tuned!